Navigation Links
China Cord Blood Corporation Forms Zhejiang Subsidiary
Date:2/22/2011

HONG KONG, Feb.22, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or "the Company"), the first and largest cord blood banking operator in China, today announced the formation of Zhejiang Lukou Biotechnology Co., Ltd. ("Zhejiang Lukou"), an indirect non-wholly owned subsidiary with the Zhejiang Provincial Blood Center, pursuant to the Company's framework agreement announced in September 2010.  Zhejiang Lukou, which is 90% owned by CCBC, will operate, on an exclusive basis, its cord blood banking services in the Zhejiang province.  

Under China's "One License per Region" policy, only one cord blood bank license is granted per province or municipality.  The Zhejiang cord blood banking license would be the seventh license granted in China and represents the first license issued since 2008.  Operating the Zhejiang subsidiary will broaden CCBC's coverage into the new and previously untapped market of the Zhejiang province.  

Ms. Ting Zheng, Chairperson and CEO of China Cord Blood Corporation, stated, "We continue to make solid progress on the commercialization of our Zhejiang cord blood banking operation, and today's announcement is an important step toward commercializing our services in this previously untapped region.  We are excited about the opening of Zhejiang Lukou, and from there, the next step in developing the Zhejiang market is infrastructure construction and building up our team, followed by a series of pre-marketing initiatives and early-stage market education activities.  By replicating our successes in Beijing and Guangdong, we are confident that the Zhejiang operation will commence in a timely and efficient manner."

Zhejiang is one of the more affluent regions in China, after Shanghai, Beijing and Guangdong, with a birthrate of over 520,000 newborns per annum, according to the Natio
'/>"/>

SOURCE China Cord Blood Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. China Cord Blood Corporation Announces Results of 2010 Annual General Meeting
2. China Cord Blood Corporation to Announce Third Quarter Fiscal 2011 Financial Results
3. China-Biotics to Report Fiscal Year 2011 Third Quarter Financial Results on February 9
4. China-Biotics, Inc. Provides Preliminary FY2011Third Quarter Revenue
5. Reportlinker Adds Industrial Biotechnology China News 1011
6. Reportlinker Adds Financial Health of Biotechnology and Drugs Industry in India and China
7. China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on February 18, 2011
8. China-Biotics, Inc. to Hold 2010 Annual Meeting of Stockholders on March 9, 2011
9. China Cord Blood Corporation Announces Completion of Warrant Exchange
10. China-Biotics Announces Redemption of $25 million in Senior Convertible Notes
11. China Cord Blood Corporation Announces Participation at the 29th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... May 28, 2015 In two different ... L. Sherley, M.D., Ph.D., will present the company’s unique ... In a conference talk, he will describe Asymmetrex ... designs with computer simulation to produce the first-ever technology ... and quality over time in culture. When leading ...
(Date:5/27/2015)... DUBLIN , May 26, 2015 ... addition of the "Global Breast Cancer Monoclonal ... offering. Globally, Roche seems to dominate ... largest inventory. Its block buster molecule, Herceptin has ... years. It was found that breast cancer cells ...
(Date:5/27/2015)... The ALS Therapy Development Institute ... owned subsidiary, Anelixis Therapeutics , $1.5 million toward ... targets the innate immune system. The funding comes from ... from the 2014 social media phenomenon known as the ... million raised directly by the Institute through last year’s ...
(Date:5/27/2015)... THOUSAND OAKS, Calif. , May 27, 2015 /PRNewswire/ ... company, has been awarded a U.S. patent for a ... gene in areas such as research, product development and ... useful in regulating key biosynthetic processes that are the ... to offer other seed companies a commercial license to ...
Breaking Biology Technology:Asymmetrex Will Discuss the Importance of Adult Tissue Stem Cell Time with 3D Tissue Engineers at the 14th Annual World Preclinical Congress in Boston in June 2Asymmetrex Will Discuss the Importance of Adult Tissue Stem Cell Time with 3D Tissue Engineers at the 14th Annual World Preclinical Congress in Boston in June 3Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 2Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 3Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 2Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 3Ceres Awarded Patent for Innovation in Soybean 2Ceres Awarded Patent for Innovation in Soybean 3
... 28 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ... (NASDAQ: ATHX) announced positive results from its phase ... therapy product, administered to individuals following acute myocardial ... heart attack. The study results, which represent at ...
... CLEVELAND, Ohio , ... leading provider of medical education and simulation training,products for ... the company,s continued global expansion. Simbionix has increased,the size ... of its Corporate,Headquarters in Cleveland, OH , and ...
... Researchers have discovered mechanisms critical to interactions between hot ... fusion reactor, part of work aimed at developing coatings ... Fusion powers the stars and could lead to ... plant would produce 10 times more energy than a ...
Cached Biology Technology:Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patients 2Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patients 3Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patients 4Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patients 5Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patients 6Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patients 7Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patients 8Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patients 9Simbionix Continues its Global Expansion 2Findings show promise for nuclear fusion test reactors 2Findings show promise for nuclear fusion test reactors 3
(Date:5/19/2015)... 2015 Fingerprint Cards (FPC) has received ... FPC1155 and FPC1035 from one if its module partners. Deliveries ... Q3 2015 and the sensors will be used by smartphone ... for 2015 hereby amount to 740 MSEK to date. In ... MSEK and a number of smaller orders not separately communicated ...
(Date:5/14/2015)... 14, 2015  Verificient Technologies, Inc., a ... online remote proctoring, announced a new alliance ... and creator of the Canvas Learning Management ... companies will benefit from the seamless integration ... As a fully integrated multifactor biometrics behavioral ...
(Date:5/8/2015)... Calif. , May 8, 2015 Synaptics Inc. ... solutions, today announced that members of the executive management team ... Morgan 43rd Annual Technology, Media and Telecom Conference Date: ... Hotel in Boston, MA ... 27, 2015 Time: 2:45pm ET Location: The New York Palace ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Synaptics to Present at Upcoming Investor Conferences 2
... consume foods purchased in vending machines are more likely to ... with being overweight, obese or at risk for chronic health ... research from the University of Michigan Medical School. The ... bars and other related sales that compete with USDA lunch ...
... PASADENA, Calif.Researchers at the California Institute of Technology ... carbon just one atom thickto visualize the structure of ... first direct images of how water coats surfaces at ... potentially unlimited number of other molecules, including antibodies and ...
... A new study from the Center for Interdisciplinary Chronobiological ... additional link between Light At Night (LAN) and cancer. ... out at the University of Haifa that also established ... ,environmental light pollution, which the study has shown is ...
Cached Biology News:Children who eat vended snack foods face chronic health problems, poor diet 2Caltech chemists develop simple technique to visualize atomic-scale structures 2Caltech chemists develop simple technique to visualize atomic-scale structures 3Connection between light at night and cancer revealed in additional study 2